QZQinghua Zhang

Qinghua Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qinghua Zhang has a total of 76 co-authors. Here are the top co-authors by number of shared publications:

  • Yang Yu

    Neurosurgery department of Huazhong University of Science and Technology Unions Shenzhen Hospital, Shenzhen Nanshan Hospital; Shenzhen 518052, China

    4 shared publications
  • Run Wang

    Department of Neurosurgery, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, China

    3 shared publications
  • Xianjin Chen

    Department of Neurosurgery, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University, Shenzhen, China

    3 shared publications
  • Xinglong Li

    Department of Neurosurgery, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University, Shenzhen, China

    3 shared publications
  • Gelei Xiao

    Department of Neurosurgery, Xiangya Hospital Central South University Changsha Hunan China

    2 shared publications
  • Peizhi Xu

    Department of Neurosurgery, Shenzhen Nanshan People’s Hospital, Shenzhen, Shenzhen, China

    2 shared publications

Latest Publications

  • Open Access

    A case report of secondary complex hydrocephalus following surgical treatment of bilateral intraventricular empyema

    by Qiqi He, Haibo Liu, Juncheng Wang, Yifei Li, Xiang Liu, Jian Yao, Wenjiong Hao, Qinghua Zhang, Peng Gao, Xin Qian

    Background: Bilateral intraventricular empyema is a rare and severe intracranial infection that may lead to ventricular adhesions and secondary complex hydrocephalus, posing substantial therapeutic challenges. Case presentation: A 52-year-old man with recent pneumonia and a 5-year history of type 2 diabetes mellitus presented with altered consciousness, fever, cough, headache, and fatigue. Lumbar puncture revealed an opening pressure of 240 mmH₂O . Cerebrospinal fluid analysis showed a white blood cell count of 1,840/mm 3 (61% neutrophils) and a protein concentration of 3.68 g/L. Imaging findings were consistent with bilateral intraventricular empyema, and cultures identified Streptococcus intermedius . Left occipital horn puncture with external ventricular drainage and neuroendoscopic evacuation of the right intraventricular empyema were performed, followed by targeted antimicrobial therapy. Results: The intraventricular purulent material progressively decreased, and the ventricular drainage catheters were removed on postoperative days 8 and 15. On postoperative day 20, secondary complex hydrocephalus developed, requiring Ommaya reservoir placement. Fourteen days later, the patient developed recurrent coma with bilateral fixed, dilated pupils (5 mm), accompanied by enlargement of the isolated right temporal horn and fourth ventricle. Combined lumboperitoneal and ventriculoperitoneal shunting was subsequently performed. The patient's neurological condition progressively improved, and follow-up CT demonstrated improvement in ventricular dilatation. Conclusion: This case highlights the challenges of managing intraventricular empyema complicated by secondary complex hydrocephalus. Neuroendoscopic evacuation may be considered in selected patients, while subsequent CSF diversion should be individualized according to changes in ventricular morphology.

  • Top Cited Papers
    Open Access

    Therapeutic Hypothermia Alleviates Hydrocephalus and Neurological Dysfunction Post Intraventricular Hemorrhage by Enhancing Drainage of Glymphatic‐Meningeal Lymphatic‐Deep Cervical Lymphatic System

    by Yijian Yang, Qian Ouyang, Yaxin Sun, Aijun Liang, Junqiang Wang, Kaiyue Wang, Yexin Yuan, Zhikun Liu, Jun Huang, Zhiping Zhang, et al.

    Aims: Intraventricular hemorrhage (IVH) has a high mortality and disability rate and poses significant clinical challenges, which often leads to hydrocephalus and neurological dysfunction. Emerging evidence implicates dysfunction of the glymphatic‐meningeal lymphatic‐deep cervical lymphatic system in the pathogenesis of post‐IVH hydrocephalus. Therapeutic hypothermia (TH) holds promise for mitigating these sequelae. This study investigates the potential of TH to ameliorate IVH‐induced hydrocephalus and neurological dysfunction, while elucidating its underlying mechanisms. Methods: Rat models of IVH are established by intraventricular injection of autologous blood. TH, deep cervical lymph nodes (dCLNs) ligation, and intraperitoneal injection of AMPK inhibitor are used to intervene. Results: In rat models of IVH, TH alleviates neurological dysfunction and attenuates hydrocephalus and pathology damage. TH protects physiological function and maintains normal structure of the glymphatic system. TH improves function and structure of the meningeal lymphatic system and promotes drainage of the deep cervical lymphatic system. TH upregulates RTN3, facilitates phosphorylation of AMPK, and suppresses ERS. All the above effects are reversed by ligation of dCLNs and AMPK inhibitor. Conclusion: TH alleviates hydrocephalus and neurological dysfunction post IVH by enhancing drainage of the glymphatic‐meningeal lymphatic‐deep cervical lymphatic system. The RTN3/AMPK/ERS pathway may be the proposed mechanism mediating this effect. TH is expected to become a novel therapeutic strategy for IVH.


  • Open Access

    Comprehensive bioinformatics analysis identified HMGB3 as a promising immunotherapy target for glioblastoma multiforme

    by Libin Wang, Peizhi Xu, Xinglong Li, Qinghua Zhang

    Objective Glioblastoma multiforme (GBM) presents significant therapeutic challenges due to its heterogeneous tumorigenicity, drug resistance, and immunosuppression. Although several molecular markers have been developed, there still lack of sensitive molecular for accurately detection. Studying the mechanisms underlying the development of GBM and finding relevant prognostic biomarkers remains crucial. Methods Single-cell RNA sequencing, bulk RNA-seq, and cancer immune cycle activities of GBM were used to assess the expression of different molecular related to GBM. Bioinformatics analyses were carried to evaluate the functional of the high mobility group protein B3 (HMGB3) in GBM. Results HMGB3 was highly expressed in GBM tissues and influenced the interpatient and intratumoral transcriptomic heterogeneity as well as immunosuppression in GBM. HMGB3 also contributes to a no inflamed tumor microenvironment (TME) and has an inhibitory effect on tumor-associated immune cell infiltration. Besides, HMGB3 participated GBM chemotherapeutic sensitivity and negative correlation with 140 medicines. Conclusion HMGB3 as a heterogeneous and immunosuppressive molecule in the GBM TME, making it a potential target for precision therapy for GBM.


  • Design of a New Dual-Modal Ultrasonic Skull Cutting Device

    by Zijun Dai, Guoqing Wang, Qinghua Zhang, Shuai Wang

  • Open Access

    Comparative analysis of clinical characteristics of symptomatic pituitary adenomas in elderly patients: a consecutive series of 114 patients

    by Run Wang, Xiaodi Han, Cheng Xie, Qinghua Zhang, Liang Kan, Sheng Han

    Background: Pituitary adenomas (PAs) present with clinical features such as neuroendocrine abnormalities and mass effects, common in the general morbidity population. However, in elderly patients, the disease progression renders some clinical features difficult to detect and identify in time. Consequently, elderly patients with PAs are often not identified and receive sufficient intervention on time to achieve a satisfactory outcome.Methods: Clinical data were collected from 114 consecutive patients older than 70 years with PAs who had undergone surgery. Based on the average age, the patients were categorized into a younger group and an elder group, and were statistically analyzed and compared.Results: Sixty-five males (57.0%) and 49 females (43.0%) were included in the study, with an average age of 73.2 years. Their common preoperative symptoms included vision impairment, followed by headache and vomiting, and visual field defect. The milder the preoperative visual impairment, the greater the possibility of post-operative visual improvement (P=0.001). The tumors were primarily non-functional pituitary adenomas (NFPAs, 73.7%), with a high degree of suprasellar invasion but a low degree of parasellar invasion (P<0.0001). For further analysis, based on the average age, we categorized the patients into younger (age< 73 years, 59 cases) and elder (age≥ 73 years, 55 cases) groups. The elder group was more likely to have preoperative vision impairment problems (P=0.044), whilst post-operative visual improvement was worse (P=0.001). The elder group also had a more severe suprasellar invasion (P=0.009), with a higher proportion of NFPA than the younger group (P=0.006). Compared to the younger group, the tumors in the elder group were larger (P=0.039), and had a higher rate of apoplexy (P=0.039), and were more likely to have comorbid postoperative complications (P=0.031), such as fever and cerebrospinal fluid (CSF) leakage, compared to the younger group.Conclusions: Elderly patients with PA had specific clinical characteristics. Their relatively worse pre- and post-operative conditions and intraoperative findings illustrated the need for early surgery.


  • Open Access

    VDMNet: A Deep Learning Framework with Vessel Dynamic Convolution and Multi-Scale Fusion for Retinal Vessel Segmentation

    by Guiwen Xu, Tao Hu, Qinghua Zhang

    Retinal vessel segmentation is crucial for diagnosing and monitoring ophthalmic and systemic diseases. Optical Coherence Tomography Angiography (OCTA) enables detailed imaging of the retinal microvasculature, but existing methods for OCTA segmentation face significant limitations, such as susceptibility to noise, difficulty in handling class imbalance, and challenges in accurately segmenting complex vascular morphologies. In this study, we propose VDMNet, a novel segmentation network designed to overcome these challenges by integrating several advanced components. Firstly, we introduce the Fast Multi-Head Self-Attention (FastMHSA) module to effectively capture both global and local features, enhancing the network’s robustness against complex backgrounds and pathological interference. Secondly, the Vessel Dynamic Convolution (VDConv) module is designed to dynamically adapt to curved and crossing vessels, thereby improving the segmentation of complex morphologies. Furthermore, we employ the Multi-Scale Fusion (MSF) mechanism to aggregate features across multiple scales, enhancing the detection of fine vessels while maintaining vascular continuity. Finally, we propose Weighted Asymmetric Focal Tversky Loss (WAFT Loss) to address class imbalance issues, focusing on the accurate segmentation of small and difficult-to-detect vessels. The proposed framework was evaluated on the publicly available ROSE-1 and OCTA-3M datasets. Experimental results demonstrated that our model effectively preserved the edge information of tiny vessels and achieved state-of-the-art performance in retinal vessel segmentation across several evaluation metrics. These improvements highlight VDMNet’s superior ability to capture both fine vascular details and overall vessel connectivity, making it a robust solution for retinal vessel segmentation.


  • Open Access

    Engineered PDGFA-ligand-modified exosomes delivery T3 for demyelinating disease targeted therapy

    by Li-Bin Wang, Bao-Ying Liao, Yong-Jun Li, Zhen-Hai Wang, Yang Yu, Xing Li, Qing-Hua Zhang


  • Registration of Structured Light Camera Point Cloud Data with CT Images

    by Wencong Chen, Juqing Song, Shuai Wang, Qinghua Zhang

  • Sodium hydrosulfide inhibits hemin-induced ferroptosis and lipid peroxidation in BV2 cells via the CBS/H2S system

    by Yang Yu, Xinghui Li, Xiuquan Wu, Xinglong Li, Jialiang Wei, Xianjin Chen, Zhouyuan Sun, Qinghua Zhang


  • Open Access

    Bioinformatics Approach Based on the Cancer-Immune Cycle Identifies Potential Immunotherapeutic Targets in Diffuse Gliomas

    by Qinghua Zhang, Xinglong Li, Run Wang, Yang Yu, Mao Li, Peizhi Xu

    Immunotherapy as monotherapies for diffuse gliomas fails to achieve satisfying results, while immunosuppression shows a greater challenge. Therefore, identifying immunosuppressive targets and developing novel combination treatments for immunotherapy could be promising. First, we tried to combine the cancer-immunity cycle score and diffuse glioma transcriptome data for weighted gene co-expression network analysis. We found significant gene modules and hub genes based on module membership (MMhub) statistics and protein-protein interaction networks (PPIhub). Then, we further obtained 37 common genes among MMhub and PPIhub. GO analysis revealed that these genes were significantly involved in the chemical synaptic transmission, glutamatergic synapse, and syntaxin-1 binding. The KEGG pathway analysis revealed they were enriched with the synaptic vesicle cycle, and glutamatergic synapse. Then, we identified 10 critical hub genes (SYN1, SNAP25, STXBP1, VAMP2, APBA1, DLG4, CPLX1, RIMS1, UNC13A, and GRIN1) using the Degree algorithms of cytoHubba plug-in. Finally, we further confirmed that these hub genes shape an immunosuppressive TME based on the evidence that they are negatively correlated with a majority of the immunological status of TME in diffuse gliomas. The result shows that these genes may be potentially unreported immunosuppressive targets in diffuse gliomas.